glp 1 ra for weight loss Direct and indirect effects of GLP1‐RA in obesity, T2D and MASLD Association between plausible genetic factors

12,58,59 In a comprehensive systematic review and meta-analysis including more than 34,000 patients with T2DM, semaglutide therapy was not associated with an increased risk of pancreatitis

Oxidative Med Cell Longev Zhao F, Zhang J, Chang N (2018) Epigenetic modification of Nrf2 by sulforaphane increases the antioxidative and anti-inflammatory capacity in a cellular model of Alzheimers disease

doi: 10.1016/S03037207(01)003860 279 NohMYKimYSLeeKYLeeYJKimSHYuHJet al

EC 1.11.1.6)

When patients respond inadequately to one GLP-1 agent, data now supports switching to or adding the complementary GLP-1/GIP dual agonist (tirzepatide) rather than introducing a second drug class like phentermine